BioNJ held its 12th Annual BioPartnering Conference from May 9-11, bringing together players from across the life sciences spectrum for a multi-day, hybrid event to foster connections, provide education and promote networking.
Partnering meetings took place throughout the course of the conference, which convened more than 500 professionals from 11 countries and 18 states, including Washington, D.C., and attracted more than 100 investors.
Hart
“We couldn’t be happier with the outcome of last week’s event,” said BioNJ President and CEO Debbie Hart. “The Conference is about growing the ecosystem and partnering to bolster medical innovation. We thank our speakers, sponsors, planning team, judges, company and institution presenters and all who attended for making this program such a success.”
More than 50 startups gave virtual presentations at the event in the hopes of attracting potential investors and partners. Videos ran a few minutes, with speakers and slides illuminating the innovations of each. After the presentations played, time was allotted to pose questions to the presenting companies.
Judges chose winners based on market opportunity, unmet need, overall innovation, differentiation and IP. One company from each presentation track was recognized, each receiving an award sponsored by BioNJ member EisnerAmper.
“Congratulations to all the winners of BioNJ’s BioPartnering Conference who are harnessing new technologies and information to improve the health and well-being of Patients — and redefining the future of health care. Innovation defines this industry,” said EisnerAmper Partner and National Biotech Sector Leader Marc Fogarty. “EisnerAmper is a proud sponsor of BioNJ, and we’re passionate about supporting the bioscience community.”
BioNJ’s 2022 Company and Pitch Presentation Awardees:
Devices & Diagnostics
- AGelity Biomechanics presented by CEO Dennis O’Dowd
Digital Medicine/Health IT/AI/Medtech
- Genetika+ presented by CEO and co-founder Talia Cohen Solal
Research & Development
- Silence Therapeutics presented by President and CEO Craig Tooman
Start-Up Pitch Presentations
- MetasTx presented by CEO Harvey Homan
Therapeutics
There were two different rooms for presentations in this category due to the number of participants; one of those rooms had a tie, for a total of three winners in the subsection.
- Adiso Therapeutics presented by CEO Scott Megaffin
- Gamida Cell presented by Chief Operating and Chief Commercial Officer Michele Korfin
- NexT Therapeutics presented by Columbia University Associate Research Scientist Dr. Mohsen Khosravi Maharlooei
Next month, BioNJ will hold its Annual Dinner Meeting and Innovation Celebration at the Hilton East Brunswick; more information is available here.
